Do you really need a drug for your bones?
by Dr. Susan E. Brown, PhD
There are several categories of drugs being prescribed in the name of bone protection.
In this article we discuss findings on the group known as bisphosphonates.
You’ve probably seen advertisements everywhere featuring a popular celebrity who
warns you about bone loss right before endorsing a certain prescription drug.
While these ads may help somewhat in increasing our awareness about the importance
of bone health, I so wish I had as much money as the big pharmaceutical companies
in order to loudly broadcast the one message you should hear: you probably don’t
really need a drug for healthy bones.
Possible adverse side effects associated with osteoporosis medications (bisphosphonates)
- Ulcers of the esophagus
- Upper GI irritation
- Irregular heartbeat
- Fractures of the femur
- Low calcium in the blood
- Skin rash
- Joint, bone, and muscle pain
- Jaw bone decay (osteonecrosis) (rare)
- Increased parathyroid hormone (PTH)
My reasoning is based on my research and experience which both show the most popular
forms of prescription medication — bisphosphonates (with the brand names Fosamax,
Actonel, or Boniva) — are not the best way to prevent osteoporosis and fracture,
may even hurt bone after continued use, and carry the risk of dangerous side effects.
As your bone health advocate, I encourage you to look carefully at any drug so you
can make an informed decision about your personal treatment.
Take the Surgeon General’s advice — work with nature to protect bone health
If you are concerned about your bone health, I’m not the only one urging you to
question the use of bisphosphonates as your first step. In 2004, the Surgeon General
provided the following pyramid as guidance for protecting bone health:
- At the base (or what should be tried first): Prevention and treatment that starts
with nutrition, physical activity, and fall prevention.
- The second tier involves assessing and treating the underlying causes of compromised
- The very tip of the pyramid, and the last resort, is pharmacotherapy — use of bone
Unfortunately, many practitioners have turned this pyramid on its head, and prescribe
bone drugs before trying anything else. It may seem easy to simply pop a pill and
forget about it, but prescription medication is rarely easy on your body.
How bisphosphonates are supposed to work
Your practitioner may recommend a bisphosphonate based on the drug’s design to slow
or stop the loss of bone density. The molecules of the drug attach themselves to
the mineral surfaces in both cortical (outer compact bone) and trabecular
(inner spongy matrix) bone to give an apparent increase in bone mass and a strengthening
effect. It does this by preventing perforations that can weaken bone structure,
as well as by interfering with cells that break down old bone — known as osteoclasts.
This means resorption, the natural process of clearing out old bone, is
inhibited, so that existing bone stays put for much longer periods than usual.
However... we know that there is a lag time during the
first six to 12 months after starting the drugs, when the bone continues to build
and stops being broken down. This initial uncoupling of the natural bone turnover
process explains why results on bone density testing appear dramatic in the first
year on a bisphosphonate.
But after a year, things start to change...
Bisphosphonates stop bone formation
Research shows that after the first year, markers for bone turnover — growth
and resorption — go down dramatically . So bone is neither building up
nor breaking down once you’ve been taking a bisphosphonate for more than a year
While women who take bisphosphonates may appear to have denser bone initially on
a bone scan, it doesn’t mean the bone is actually stronger. In fact, we know that
bone naturally becomes less dense as we age, but what protects us from debilitating
fracture is our inborn ability to repair, meaning to break down old bone and rebuild
new bone naturally as part of a cycle.
And because this natural bone repair process is halted by drugs, it is very likely
that long-term use will weaken, not strengthen, bone.
Dense bones may be brittle
FDA warns about bisphosphonate safety
On Oct. 23, 2010, the Food and Drug Administration (FDA) issued a public safety
notice to both patients and healthcare providers warning “there is a possible risk
of a rare type of thigh bone (femoral) fracture in people who take drugs known as
bisphosphonates to treat osteoporosis.” The FDA also required a labeling change
noting the risk.
I had a patient who had been on Fosamax for four years, then turned in her bedroom
one evening and fell to the floor, breaking her leg in two separate places.
Though these “low-trauma” and “nontraumatic” fractures aren’t happening to large
numbers of women on bisphosphonates, they certainly serve as a warning for those
considering prolonged use of these drugs as “preventive medicine.” It also points
to the fact that halting bone resorption doesn’t automatically give us stronger
bones, and may in fact make them more brittle over time.
Spinning the numbers on bone health
What’s disappointing to me is the way numbers from studies can be manipulated to
exaggerate treatment benefits. Statistical calculations are often complex and can
be presented in many different ways — depending on what you want to say!
One way to “spin the numbers” is to present the results for specifically-selected
study participants as representative of results for everyone else. In one study,
researchers asked if “real-world” patients taking bone drugs received the same fracture-reduction
benefits seen in the clinical trials. After analysis of hundreds of studies, they
found that highly compliant, “real world” patients on osteoporosis drugs experienced
a 21% reduction in all clinical fractures. This compares to the 24% overall clinical
fracture reduction experienced by subjects in osteoporosis drug clinical trials.
Now compare this 21-24% fracture-reduction benefit from bone drugs to the studies
documenting that those taking vitamin D in any dose (much less a therapeutic dose)
experience a 23-26% reduction in fractures.
These are quite different messages than the ones we often hear — how bone drugs
reduce your chance of fracture by 50% or that they are much more effective than
You have choices about bone health
There is a lot of fear and anxiety around any osteoporosis or osteopenia diagnosis.
It’s reassuring to know that your body is capable of building and strengthening
bone on its own when given the needed support and time to do so. In the end, the
choice is yours. The prescriptions advertised on television may sound and look enticing,
but the benefits are often exaggerated.
For over 25 years at our bone health center we have helped thousands of women strengthen
their bones and prevent fracture — and 90% of them have not needed drugs.
Related to this article:
References & further
reading on drug therapy
Last Modified Date: 02/03/2012
Principal Author: Dr. Susan E. Brown, PhD